Answers are grounded in this paper and cite their sources.
BACKGROUND: Epinastine is a topical ophthalmic antihistamine and a mast cell stabilizer indicated for treatment of symptoms associated with allergic conjunctivitis. OBJECTIVE: The objective of this review is to provide a comprehensive overview of the pharmacology, clinical efficacy, tolerability and safety of epinastine 0.05% ophthalmic solution. METHODS: Medline literature review from 1950 to 2008. CONCLUSIONS: Epinastine 0.05% ophthalmic solution was found to be a safe and effective medication for the relief of symptoms of allergic conjunctivitis. Epinastine demonstrates very low CNS and cardiac toxicity.
No takes yet. Share an insight, caveat, or question.
Pradhan et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: